Planta Medica International Open 2017; 4(S 01): S1-S202
DOI: 10.1055/s-0037-1608493
Poster Session
Georg Thieme Verlag KG Stuttgart · New York

Intestinal permeability induced by psychological stress: Action of STW 5

P Aubert
1   Inserm U1235-Institut des Maladies de l'Appareil Digestif du CHU de Nantes, Nantes, France
,
J Chevalier
1   Inserm U1235-Institut des Maladies de l'Appareil Digestif du CHU de Nantes, Nantes, France
,
T Durand
1   Inserm U1235-Institut des Maladies de l'Appareil Digestif du CHU de Nantes, Nantes, France
,
A Bessard
1   Inserm U1235-Institut des Maladies de l'Appareil Digestif du CHU de Nantes, Nantes, France
,
O Kelber
2   Innovation and Development, Phytomedicines Supply and Development Center, Bayer Consumer Health Division, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany, Darmstadt, Germany
,
H Abdel-Aziz
3   Medical and Clinical Affairs Phytomedicines, Innovation and Development, Phytomedicines Supply and Development Center, Bayer Consumer Health Division, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany
,
M Neunlist
1   Inserm U1235-Institut des Maladies de l'Appareil Digestif du CHU de Nantes, Nantes, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
24. Oktober 2017 (online)

 

STW 5, a herbal medicinal product, has been shown to stimulate intestinal chloride secretion. Whether it can modulate paracellular and transcellular permeability remains currently unknown. Therefore, we did study the ability of STW 5 to modulate intestinal permeability under basal and repeated acute stress conditions.

C57 bl6 mice were gavaged for 14 days with STW 5 (3 mL/kg). After 10 days of treatment, mice were subjected to water avoidance stress (WAS) during 4 consecutive days. In vivo permeability to FITC -Sulfonic Acid (FSA, 400 Da) and Horse Radish Peroxydase (HRP, 44KDa), total transit time and colonic transit (fecal pellet output – FPO) were assessed at Day 0 (D0), D10 and D14 of IB treatment. Ex vivo permeability to FSA and HRP was assessed on jejunum, ileum, proximal colon and distal colon at D14 using Ussing chambers. Corticosterone blood level was measured at D11 and D14.

While in vivo permeability to FSA and HRP as well as total transit time were not modified by STW 5 in basal and WAS conditions, STW 5 prevented the increase in permeability to FSA induced by WAS in the distal colon ex vivo. STW 5 prevented the increase in permeability to HRP induced by WAS in the jejunum and proximal colon. While STW 5 tended to increase colonic transit as compared to control in basal conditions, it did not influence the increase in colonic transit induced by WAS. STW 5 did not modify the changes in corticosterone induced by WAS.

STW 5 (Iberogast) obviously can prevent WAS induced changes in paracellular and transcellular permeability in specific regions of the gastrointestinal tract. Such effects could contribute to the therapeutic effects of STW 5 in irritable bowel syndrome and support its use in indications in which barrier functions are altered.